These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 385948)

  • 41. Immunotherapy for acute myelogenous leukemia.
    Powles RL; Lister TA; Crowther D; McElwain T; Alexander P; Fairley GH
    Bibl Haematol; 1975; (40):737-49. PubMed ID: 1057948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunology and immunotherapy of leukemia (basic results of 8-years research)].
    Bergol'ts VM
    Vopr Onkol; 1978; 24(11):16-24. PubMed ID: 283626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemoimmunotherapy for maintenance in acute myeloblastic leukemia.
    Whiteside MG; Cauchi MN; Paton C; Stone J
    Cancer; 1976 Oct; 38(4):1581-6. PubMed ID: 1068741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized controlled study of chemoimmunotherapy of acute myelogenous leukemia (AML) in adults with Nocardia rubra cell-wall skeleton and irradiated allogeneic AML cells.
    Ohno R; Nakamura H; Kodera Y; Ezaki K; Yokomaku S; Oguma S; Kubota Y; Shibata H; Ogawa N; Masaoka T
    Cancer; 1986 Apr; 57(8):1483-8. PubMed ID: 3512070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy and immunotherapy for acute myelogenous leukemia.
    Lister TA; Whitehouse JM; Oliver RT; Bell R; Johnson SA; Wrigley PF; Ford JM; Cullen MH; Gregory W; Paxton AM; Malpas JS
    Cancer; 1980 Nov; 46(10):2142-8. PubMed ID: 6932992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of leukemia specific antigen and immunotherapy of acute leukemia with cell-wall skeleton of BCG.
    Ohno R; Ezaki K; Morishima Y; Kodera Y; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1134-41. PubMed ID: 87101
    [No Abstract]   [Full Text] [Related]  

  • 47. Progress report on immunotherapy of chronic myeloid leukemia.
    Sokal JE; Carpenter N; Nizet C
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):294-305. PubMed ID: 282900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotherapy for acute myelogenous leukaemia.
    Powles RL; Crowther D; Bateman CJ; Beard ME; McElwain TJ; Russell J; Lister TA; Whitehouse JM; Wrigley PF; Pike M; Alexander P; Fairley GH
    Br J Cancer; 1973 Nov; 28(5):365-76. PubMed ID: 4271320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
    Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
    Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.
    Powles RL; Russell J; Lister TA; Oliver T; Whitehouse JM; Malpas J; Chapuis B; Crowther D; Alexander P
    Br J Cancer; 1977 Mar; 35(3):265-72. PubMed ID: 322689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL.
    Baehner RL; Bernstein ID; Sather H; Higgins G; McCreadie S; Chard RL; Hammond D
    Med Pediatr Oncol; 1979; 7(2):127-39. PubMed ID: 291771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunotherapy for acute myelogenous leukemia with Nocardia rubra cell-wall skeleton. A randomized controlled study].
    Nakamura H; Masaoka T; Ohno R; Yamada K; Ogawa N
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1087-92. PubMed ID: 6582752
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunotherapy of acute myeloid leukaemia. Medical Research Council.
    Br J Cancer; 1978 Jan; 37(1):1-14. PubMed ID: 339940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Adjuvant activity of Nocardia cell-wall skeleton on maintenance chemotherapy of acute non-lymphatic leukemia].
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1093-8. PubMed ID: 6364675
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cytogenetic studies following immune induction therapy].
    Kirchner M; Jahn G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(1):29-36. PubMed ID: 58816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immunotherapy of acute myelogenous leukaemia using intravenous BCG.
    Whittaker JA; Slater AJ
    Br J Haematol; 1977 Feb; 35(2):263-73. PubMed ID: 322696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia.
    Ezaki K; Hersh EM; Keating M; Dyre S; Hollinshead A; McCredie KB; Mavlight GM; Gutterman JU
    Cancer; 1978 Jan; 41(1):70-83. PubMed ID: 75055
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunologic maneuvers in the management of acute leukemia.
    Powles RL
    Med Clin North Am; 1976 May; 60(3):463-72. PubMed ID: 131888
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.
    Summerfield GP; Gibbs TJ; Bellingham AJ
    Br J Cancer; 1979 Nov; 40(5):736-42. PubMed ID: 389265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mixed lymphocyte-tumor cell reaction between remission lymphocytes and autochthonous leukemia cells and its relationship to the prognosis of acute leukemia.
    Ohno R; Ezaki K; Kodera Y; Tanimoto M; Yamada K
    Gan; 1980 Aug; 71(4):451-6. PubMed ID: 6448761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.